17283-14-6 Usage
General Description
3,4-DIMETHYLPHENETHYLAMINE, also known as 3,4-Dimethylphenethylamine or 3,4-DMPA, is a chemical compound often used as a dietary supplement and bodybuilding aid. It is a derivative of phenethylamine and is structurally similar to amphetamines, exhibiting stimulant properties. 3,4-DIMETHYLPHENETHYLAMINE is known for its potential to increase energy, focus, and athletic performance, and is often included in pre-workout supplements and weight loss products. It functions by enhancing the release of certain neurotransmitters in the brain, resulting in heightened activity levels and improved mental alertness. However, there is limited scientific research on its efficacy and safety, and it has been banned as a dietary ingredient in the U.S. by the Food and Drug Administration due to concerns about potential health risks and lack of evidence supporting its safety and effectiveness.
Check Digit Verification of cas no
The CAS Registry Mumber 17283-14-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,2,8 and 3 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 17283-14:
(7*1)+(6*7)+(5*2)+(4*8)+(3*3)+(2*1)+(1*4)=106
106 % 10 = 6
So 17283-14-6 is a valid CAS Registry Number.
InChI:InChI=1/C10H15N/c1-8-3-4-10(5-6-11)7-9(8)2/h3-4,7H,5-6,11H2,1-2H3
17283-14-6Relevant articles and documents
Phenylacetamide derivatives and pharmaceutical compositions thereof
-
, (2008/06/13)
The present invention provides novel phenylacetamide derivatives having the following formula STR1 wherein: X is a hydrogen, halogen, hydroxy, nitro, amino, R1, NR1 R2, NHR1 or OR1 wherein R1/su
Process for the preparation of (8As,12AS,13AS)-decahydroisoquino ((2,1-G) (1,6)-naphthyridin-8-one derivatives
-
, (2008/06/13)
The invention provides a process for preparing single enantiomers of compounds represented by the formula: STR1 and chiral acid addition salts thereof; wherein: X and Y are independently hydrogen; lower alkyl; lower alkoxy; or halo; or X and Y taken together is methylenedioxy or ethylene-1,2-dioxy; which includes reduction of a compound represented by the formula: STR2 to give a mixture of stereoisomers represented by the formula: STR3 wherein each wavy line independently represents a bond in either the α or β position; followed by dissolving the mixture of stereoisomers and a chiral resolving acid in a suitable solvent and allowing the solution to crystallize, giving a salt of the desired enantiomer.
